- Home
- CVX vs AZN Comparison
CVX vs AZN Comparison
Compare CVX & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CVX | AZN |
|---|---|---|
| Founded | 1879 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.2B | 283.9B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | CVX | AZN |
|---|---|---|
| Price | $161.13 | $95.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 2 |
| Target Price | ★ $172.26 | N/A |
| AVG Volume (30 Days) | ★ 10.1M | 4.8M |
| Earning Date | 01-30-2026 | 02-05-2026 |
| Dividend Yield | ★ 4.29% | 1.63% |
| EPS Growth | N/A | ★ 45.02 |
| EPS | ★ 7.09 | 6.02 |
| Revenue | ★ $188,687,000,000.00 | $58,127,000,000.00 |
| Revenue This Year | N/A | $11.40 |
| Revenue Next Year | $1.53 | $6.06 |
| P/E Ratio | $22.45 | ★ $15.62 |
| Revenue Growth | N/A | ★ 13.52 |
| 52 Week Low | $132.04 | $61.24 |
| 52 Week High | $168.96 | $96.51 |
Technical Indicators
Market Signals| Indicator | CVX | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 63.41 | 64.31 |
| Support Level | $154.90 | $93.22 |
| Resistance Level | $165.75 | $96.51 |
| Average True Range (ATR) | 2.92 | 1.41 |
| MACD | 1.17 | 0.18 |
| Stochastic Oscillator | 77.19 | 81.52 |
Price Performance
Historical ComparisonAbout CVX Chevron Corporation
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.0 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.7 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2024 stood at 9.8 billion barrels of oil equivalent, including 5.1 billion barrels of liquids and 28.4 trillion cubic feet of natural gas.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.